Avoiding Trouble Down the Line: The Management and Prevention of Hemodialysis Catheter-Related Infections

Advances in Chronic Kidney Disease

Volumn 13, Issue 3, 2006, Pages 225-244

  Lok, Charmaine E ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Antibiotic; Antimicrobial; Bacteremia; Central venous catheters; Hemodialysis

Indexed keywords

2 PROPANOL; ALTEPLASE; AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; ANTIBIOTIC AGENT; BACITRACIN; BACTERIAL VACCINE; CEFAZOLIN; CHLORHEXIDINE; CIPROFLOXACIN; FIBRINOLYTIC AGENT; GENTAMICIN; METICILLIN; MINOCYCLINE; NAFCILLIN; POLYSPORIN; POVIDONE IODINE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SILVER; SULFADIAZINE SILVER; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BIOFILM; BLOOD CULTURE; CANDIDA; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPARATIVE STUDY; CULTURE TECHNIQUE; EMBOLISM; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HONEY; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; INSTRUMENT STERILIZATION; MICROBIAL COLONIZATION; MOLECULAR TYPING; MORTALITY; OSTEOMYELITIS; OTOTOXICITY; PATHOGENESIS; PATHOPHYSIOLOGY; PERITONEAL CATHETER; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SEPTICEMIA; SKIN FLORA; STAPHYLOCOCCUS AUREUS; VASCULAR ACCESS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CATHETERS, INDWELLING; HUMANS; PROGNOSIS; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS;

EID: 33745387611     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2006.04.009     Document Type: Article

References (150)

1. Dunn J., Nylander W., and Richie R. Central venous dialysis access. Experience with a dual-lumen, silicone rubber catheter. Surgery 102 (1987) 784-789
2. US Renal Data System. USRDS 2005 Annual Data Report. Atlas of Endstage Renal Disease in the United States, in Incidence and Prevalence; Patient Characteristics (2005), National Institues of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Betheseda, MD
3. Mendelssohn D.C., Ethier J., Elder S.J., et al. Haemodialysis vascular access problems in Canada. Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 21 (2005) 721-728
4. Lee T., Barker J., and Allon M. Tunneled catheters in hemodialysis patients. Reasons and subsequent outcomes. Am J Kidney Dis 46 (2005) 501-508
5. Oliver M.J., Lok C.E., and Shi J. Dialysis therapy for Persons with Diabetes. In: Hux J.E., Booth G.L., Slaughter P.M., et al. (Eds). Diabetes in Ontario. An ICES Practice Atlas (2002), Institute for Clinical Evaluative Sciences, Toronto 165-180
6. Ethier J.H., Lindsay R.M., Barre P.E., et al., Canadian Society of Nephrology. Clinical practice guidelines for vascular access. J Am Soc Nephrol 10 suppl 13 (1999) S297-S305
7. Foundation NK. K/DOQI clinical practice guidelines for vascular access, 2000. Am J Kidney Dis 27 (2001) S137-S181
8. Schaubel D.E., and Fenton S.S.A. Trends in mortlaity rates on hemodialysis in Canada, 1981-1997. Kidney Int 57 (2000) S66-S73
9. Sarnak M.J., and Jaber B.L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000 58 (2000) 1758-1764
10. Tokars J.I., Miller E.R., and Stein G. New national surveillance system for hemodialysis-associated infections. Initial results. Am J Infect Control 30 (2002) 288-295
11. Hoen B., Paul-Dauphin A., Hestin D., et al. EPIBACDIAL. A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 9 (1998) 869-876
12. Lentino J.R., Baddour L.M., Wray M., et al. Staphylococcus aureus and other bacteremias in hemodialysis patients. Antibiotic therapy and surgical removal of access site. Infection 28 (2000) 355-360
13. Reed S.D., Friedman J.Y., Engemann J.J., et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26 (2005) 175-183
14. Stevenson K.B., Hannah E.L., Lowder C.A., et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data. Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39 (2002) 549-555
15. Dopirak M., Hill C., Oleksiw M., et al. Surveillance of hemodialysis-associated primary bloodstream infections. The experience of ten hospital-based centers. Infect Control Hosp Epidemiol 23 (2002) 721-724
16. Taylor G., Gravel D., Johnston L., et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 32 (2004) 155-160
17. Dhingra R.K., Young E.W., Hulbert-Shearon T.E., et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60 (2001) 1443-1451
18. Ishani A., Collins A.J., Herzog C.A., et al. Septicemia, access and cardiovascular disease in dialysis patients. The USRDS Wave 2 study. Kidney Int 68 (2005) 311-318
19. Foley R.N., Guo H., Snyder J.J., et al. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol 15 (2004) 1038-1045
20. Engemann J.J., Friedman J.Y., Reed S.D., et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26 (2005) 534-539
21. Gucek A., Stanisavljevic D., Benedik M., et al. How to record peritoneal catheter infections. Adv Perit Dial 14 (1998) 145-148
22. Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 (2001) 1249-1272
23. Maki D.G., Weise C.E., and Sarafin H.W. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296 (1977) 1305-1309
24. Widmer A.F., Nettleman M., Flint K., et al. The clinical impact of culturing central venous catheters. A prospective study. Arch Intern Med 152 (1992) 1299-1302
25. Robinson D., Suhocki P., and Schwab S.J. Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 53 (1998) 1792-1794
26. Shaffer D. Catheter-related sepsis complicating long-term, tunneled central venous dialysis catheters. Management by guidewire exchange. Am J Kidney Dis 25 (1995) 593-596
27. Fan S.T., Teoh-Chan C.H., and Lau K.F. Evaluation of central venous catheter sepsis by differential quantitative blood culture. Eur J Clin Microbiol Infect Dis 8 (1989) 142-144
28. Capdevila J.A., Planes A.M., Palomar M., et al. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 11 (1992) 403-407
29. Safdar N., Fine J.P., and Maki D.G. Meta-analysis. Methods for diagnosing intravascular device-related bloodstream infection. [erratum appears in Ann Intern Med. 2005 May 3;142(9):803]. Ann Intern Med 142 (2005) 451-466
30. Blot F., Nitenberg G., Chachaty E., et al. Diagnosis of catheter-related bacteraemia. A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354 (1999) 1071-1077
31. Raad I., Hanna H.A., Alakech B., et al. Differential time to positivity. A useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 140 (2004) 18-25
32. Dobbins B.M., Kite P., Catton J.A., et al. In situ endoluminal brushing. A safe technique for the diagnosis of catheter-related bloodstream infection. J Hosp Infect 58 (2004) 233-237
33. Catton J.A., Dobbins B.M., Kite P., et al. In situ diagnosis of intravascular catheter-related bloodstream infection. A comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit Care Med 33 (2005) 787-791
34. Gaur A.H., Flynn P.M., Heine D.J., et al. Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J 24 (2005) 445-449
35. Franklin J.A., Gaur A.H., Shenep J.L., et al. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture. Pediatr Infect Dis J 23 (2004) 614-618
36. Tanguy M., Seguin P., Laviolle B., et al. Hub qualitative blood culture is useful for diagnosis of catheter-related infections in critically ill patients. Intensive Care Med 31 (2005) 645-648
37. Calandra T., Cohen J., and International Sepsis Forum Definition of Infection in the ICUCC. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33 (2005) 1538-1548
38. Preventing infections associated with indwelling intravascular access devices. Can Commun Dis Rep 23 (1997) i-iii, 1-32, i-iv1, 31-16
39. O'Grady N.P., Alexander M., Dellinger E.P., et al., Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 9 51 (2002) 1-29
40. Taylor G., Gravel D., Johnston L., et al. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. [comment]. Infect Control Hosp Epidemiol 23 (2002) 716-720
41. Fridkin S.K., Pear S.M., Williamson T.H., et al. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 17 (1996) 150-158
42. Vanherweghem J.L., Dhaene M., Goldman M., et al. Infections associated with subclavian dialysis catheters. The key role of nurse training. Nephron 42 (1986) 116-119
43. Foundation NK. NKF-K/DOQI Clinical practice guidelines for vascular access. Update 2000. Am J Kidney Dis 37 suppl 1 (2001) S137-S181
44. Eggimann P., Harbarth S., Constantin M.N., et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355 (2000) 1864-1868
45. Soifer N.E., Borzak S., Edlin B.R., et al. Prevention of peripheral venous catheter complications with an intravenous therapy team. A randomized controlled trial. Arch Intern Med 158 (1998) 473-477
46. Beathard G.A. Catheter management protocol for catheter-related bacteremia prophylaxis. Semin Dial 16 (2003) 403-405
47. Tokars J.I., Light P., Anderson J., et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 37 (2001) 1232-1240
48. Taylor G., Gravel D., Johnston L., et al. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23 (2002) 716-720
49. Seo S.K., Venkataraman L., DeGirolami P.C., et al. Molecular typing of coagulase-negative staphylococci from blood cultures does not correlate with clinical criteria for true bacteremia. Am J Med 109 (2000) 697-704
50. Khatib R., Riederer K.M., Clark J.A., et al. Coagulase-negative staphylococci in multiple blood cultures. Strain relatedness and determinants of same-strain bacteremia. J Clin Microbiol 33 (1995) 816-820
51. Raad I., Costerton W., Sabharwal U., et al. Ultrastructural analysis of indwelling vascular catheters. A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168 (1993) 400-407
52. Dittmer I.D., Sharp D., McNulty C.A., et al. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 51 (1999) 34-39
53. Johnson D.W., MacGinley R., Kay T.D., et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunneled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17 (2002) 1802-1807
54. Lok C.E., Stanley K.E., Hux J.E., et al. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 14 (2003) 169-179
55. Levin A., Mason A.J., Jindal K.K., et al. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 40 (1991) 934-938
56. Johnson D.W., van Eps C., Mudge D.W., et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 16 (2005) 1456-1462
57. Fux C.A., Uehlinger D., Bodmer T., et al. Dynamics of hemodialysis catheter colonization by coagulase-negative staphylococci. Infect Control Hosp Epidemiol 26 (2005) 567-574
58. Hoshal Jr. V.L., Ause R.G., and Hoskins P.A. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg 102 (1971) 253-258
59. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms. a common cause of persistent infections. Science 284 (1999) 1318-1322
60. Donlan R.M. Biofilm formation. A clinically relevant microbiological process. Clin Infect Dis 33 (2001) 1387-1392
61. Vandholder R., and Ringoir S. Infectious morbidity and defects of phagocytic function in end stage renal disease. A review. J Am Soc Nephrol 3 (1993) 1541-1554
62. Lopez-Lopez G., Pascual A., and Perea E.J. Effect of plastic catheter material on bacterial adherence and viability. J Med Microbiol 34 (1991) 349-353
63. Sheth N.K., Rose H.D., Franson T.R., et al. In vitro quantitative adherence of bacteria to intravascular catheters. J Surg Res 34 (1983) 213-218
64. Gilsdorf J.R., Wilson K., and Beals T.F. Bacterial colonization of intravenous catheter materials in vitro and in vivo. Surgery 106 (1989) 37-44
65. Darouiche R.O. Device-associated infections. A macroproblem that starts with microadherence. Clin Infect Dis 33 (2001) 1567-1572
66. Marr K.A., Conlon P.J., Corey G.R., et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127 (1997) 275-280
67. Powe N.R., Jaar B., Furth S.L., et al. Septicemia in dialysis patients. Incidence, risk factors, and prognosis. Kidney Int 55 (1999) 1081-1090
68. Oliver M.J., Rothwell D.M., Fung K., et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 15 (2004) 1936-1942
69. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 (2000) 391-402
70. Raad I.I., Hohn D., Gilbreath B., et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15 (1994) 231-238
71. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care. A meta-analysis. Ann Intern Med 136 (2002) 792-801
72. Nassar G.M., and Ayus J.C. Infectious complications of the hemodialysis access. Kidney Int 60 (2001) 1-13
73. Hoffmann K.K., Weber D.J., Samsa G.P., et al. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 267 (1992) 2072-2076
74. McLaughlin K., Jones B., Mactier R., et al. Long-term vascular access for hemodialysis using silicon dual-lumen catheters with guidewire replacement of catheters for technique salvage. Am J Kidney Dis 29 (1997) 553-559
75. Duszak Jr. R., Haskal Z.J., Thomas-Hawkins C., et al. Replacement of failing tunneled hemodialysis catheters through pre-existing subcutaneous tunnels. A comparison of catheter function and infection rates for de novo placements and over-the-wire exchanges. J Vasc Interv Radiol 9 (1998) 321-327
76. Richet H., Hubert B., Nitemberg G., et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 28 (1990) 2520-2525
77. Cimochowski G.E., Worley E., Rutherford W.E., et al. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54 (1990) 154-161
78. Trerotola S.O., Johnson M.S., Harris V.J., et al. Outcome of tunneled hemodialysis catheters placed via the right internal jugular vein by interventional radiologists. Radiology 203 (1997) 489-495
79. Chow K.M., Szeto C.C., Leung C.B., et al. Cuffed-tunneled femoral catheter for long-term hemodialysis. Int J Artif Organs 24 (2001) 443-446
80. Kairaitis L.K., and Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 14 (1999) 1710-1714
81. Oliver M.J., Callery S.M., Thorpe K.E., et al. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use. A prospective study. Kidney Int 58 (2000) 2543-2545
82. Wertheim H.F., Melles D.C., Vos M.C., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5 (2005) 751-762
83. Nielsen J., Ladefoged S.D., and Kolmos H.J. Dialysis catheter-related septicaemia-Focus on Staphylococcus aureus septicaemia. Nephrol Dial Transplant 13 (1998) 2847-2852
84. Ena J., Boelaert J.R., Boyken L.D., et al. Epidemiology of Staphylococcus aureus infections in patients on hemodialysis. Infect Control Hosp Epidemiol 15 (1994) 78-81
85. Yu V.L., Goetz A., Wagener M., et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 315 (1986) 91-96
86. Holton D.L., Nicolle L.E., Diley D., et al. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. J Hosp Infect 17 (1991) 133-137
87. Bommer J., Vergetis W., Andrassy K., et al. Elimination of Staphylococcus aureus in hemodialysis patients. ASAIO J 41 (1995) 127-131
88. Watanakunakorn C., Brandt J., Durkin P., et al. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am J Infect Control 20 (1992) 138-141
89. Boelaert J.R., De Smedt R.A., De Baere Y.A., et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 4 (1989) 278-281
90. Conly J.M., and Vas S. Increasing mupirocin resistance of Staphylococcus aureus in CAPD-Should it continue to be used as prophylaxis?. Perit Dial Int 22 (2002) 649-652
91. Berns J.S., and Tokars J.I. Preventing bacterial infections and antimicrobial resistance in dialysis patients. Am J Kidney Dis 40 (2002) 886-898
92. O'Grady N.P., Alexander M., Dellinger E.P., et al., Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 51 (2002) 1-29
93. Guidelines for the prevention of intravascular catheter related infections, 2002. Available at: http://www.cdc.gov/ncidod/dhqp/gl_intravascular.html, 2002. Accessed January 16, 2006
94. Riu S., Ruiz C.G., Martinez-Vea A., et al. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 13 (1998) 1870-1871
95. Khandelwal M., Bailey S., Izatt S., et al. Structural changes in silicon rubber peritoneal dialysis catheters in patients using mupirocin at the exit site. Int J Artif Organs 26 (2003) 913-917
96. Maki D.G., Cobb L., Garman J.K., et al. An attachable silver-impregnated cuff for prevention of infection with central venous catheters. A prospective randomized multicenter trial. Am J Med 85 (1988) 307-314
97. Bonawitz S.C., Hammell E.J., and Kirkpatrick J.R. Prevention of central venous catheter sepsis. A prospective randomized trial. Am Surg 57 (1991) 618-623
98. Crnich C.J., and Maki D.G. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 34 (2002) 1362-1368
99. Diskin C.J., and Stokes T.J. Efficacy of an attachable silver impregnated subcutaneous cuff for the prevention of catheter-associated infections in patients on chronic maintenance hemodialysis. Nephron 69 (1995) 357-359
100. Dahlberg P.J., Agger W.A., Singer J.R., et al. Subclavian hemodialysis catheter infections. A prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 16 (1995) 506-511
101. Bong J.J., Kite P., Wilco M.H., et al. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters. A randomised controlled trial. J Clin Pathol 56 (2003) 731-735
102. Trerotola S.O., Johnson M.S., Shah H., et al. Tunneled hemodialysis catheters. Use of a silver-coated catheter for prevention of infection-A randomized study. Radiology 207 (1998) 491-496
103. Timsit J.F., Farkas J.C., Boyer J.M., et al. Central vein catheter-related thrombosis in intensive care patients. Incidence, risks factors, and relationship with catheter-related sepsis. Chest 114 (1998) 207-213
104. Raad I.I., Luna M., Khalil S.A., et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271 (1994) 1014-1016
105. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A meta-analysis. JAMA 281 (1999) 261-267
106. Darouiche R.O., Raad I.I., Heard S.O., et al., Catheter Study Group. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 340 (1999) 1-8
107. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections. A randomized, controlled trial. Ann Intern Med 143 (2005) 570-580
108. Moran J.E. Subcutaneous vascular access devices. Semin Dial 14 (2001) 452-457
109. Schwab S.J., Rushton F., Ross J.P., et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int 62 (2002) 1026-1033
110. Beathard G.A., and Posen G.A. Initial clinical results with the LifeSite Hemodialysis Access System. Kidney Int 58 (2000) 2221-2227
111. Ross J.J., Narayan G., Bergeron E.K., et al. Infections associated with use of the LifeSite Hemodialysis Access System. Clin Infect Dis 35 (2002) 93-95
112. Hollenbeck M., Zolotov D., Debusmann E.R., et al. Use of LifeSite port systems for hemodialysis in Germany. Clin Nephrol 64 (2005) 138-143
113. Boorgu R., Dubrow A.J., Levin N.W., et al. Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J 46 (2000) 767-770
114. Canaud B., Levin N., Ing T., et al. Dialock. A pilot trial of a new vascular port access device for hemodialysis. Semin Dial 12 (1999) 382-388
115. Levin N.W., Yang P.M., Hatch D.A., et al. Initial results of a new access device for hemodialysis technical note. Kidney Int 54 (1998) 1739-1745
116. Sesso R., Barbosa D., Leme I.L., et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter. Effect of mupirocin ointment. J Am Soc Nephrol 9 (1998) 1085-1092
117. Johnson D.W., MacGinley R., Kay T.D., et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunneled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17 (2002) 1802-1807
118. Fogel M.A., Nussbaum P.B., Feintzeig I.D., et al. Cefazolin in chronic hemodialysis patients. A safe, effective alternative to vancomycin. Am J Kidney Dis 32 (1998) 401-409
119. Marx M.A., Frye R.F., Matzke G.R., et al. Cefazolin as empiric therapy in hemodialysis-related infections. Efficacy and blood concentrations. Am J Kidney Dis 32 (1998) 410-414
120. Schwab S.J., and Beathard G. The hemodialysis catheter conundrum. Hate living with them, but can't live without them. Kidney Int 56 (1999) 1-17
121. Beathard G.A. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10 (1999) 1045-1049
122. Moss A.H., Vasilakis C., Holley J.L., et al. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 16 (1990) 211-215
123. Swartz R.D., Messana J.M., Boyer C.J., et al. Successful use of cuffed central venous hemodialysis catheters inserted percutaneously. J Am Soc Nephrol 4 (1994) 1719-1725
124. Lund G.B., Trerotola S.O., Scheel Jr. P.F., et al. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 198 (1996) 467-472
125. Saad T.F. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34 (1999) 1114-1124
126. Poole C.V., Carlton D., Bimbo L., et al. Treatment of catheter-related bacteraemia with an antibiotic lock protocol. Effect of bacterial pathogen. Nephrol Dial Transplant 19 (2004) 1237-1244
127. Vardhan A., Davies J., Daryanani I., et al. Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant 17 (2002) 1149-1150
128. Bailey E., Berry N., and Cheesbrough J.S. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 50 (2002) 615-617
129. Munyal D., Ong S.W., and Lok C.E. Evaluation of hemodialysis catheter-related inections and their management. J Am Soc Nephrol 16 (2005) 454A (abstr)
130. Carlisle E.J., Blake P., McCarthy F., et al. Septicemia in long-term jugular hemodialysis catheters. Eradicating infection by changing the catheter over a guidewire. Int J Artif Organs 14 (1991) 150-153
131. Angle J.F., Shilling A.T., Schenk W.G., et al. Utility of percutaneous intervention in the management of tunneled hemodialysis catheters. Cardiovasc Intervent Radiol 26 (2003) 9-18
132. Tanriover B., Carlton D., Saddekni S., et al. Bacteremia associated with tunneled dialysis catheters. Comparison of two treatment strategies. Kidney Int 57 (2000) 2151-2155
133. Mokrzycki M.H., and Singhal A. Cost-effectiveness of three strategies of managing tunneled, cuffed haemodialysis catheters in clinically mild or asymptomatic bacteraemias. Nephrol Dial Transplant 17 (2002) 2196-2203
134. Allon M. Dialysis catheter-related bacteremia. Treatment and prophylaxis. Am J Kidney Dis 44 (2004) 779-791
135. Tokars J.I., Frank M., Alter M.J., et al. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 15 (2002) 162-171
136. Finelli L., Miller J.T., Tokars J.I., et al. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18 (2005) 52-61
137. Roghmann M.C., Fink J.C., Polish L., et al. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients. Am J Kidney Dis 32 (1998) 254-257
138. D'Agata E.M. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 35 (2002) 1212-1218
139. Stevenson K.B., Adcox M.J., Mallea M.C., et al. Standardized surveillance of hemodialysis vascular access infections. 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 21 (2000) 200-203
140. Tena D., Carranza R., Barbera J.R., et al. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit. Eur J Clin Microbiol Infect Dis 11 (2005) 727-732
141. Hannah E.L., Stevenson K.B., Lowder C.A., et al. Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters. Making the case for active infection surveillance. Infect Control Hosp Epidemiol 23 (2002) 538-541
142. Rosenthal V.D., Guzman S., Pezzotto S.M., et al. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 31 (2003) 405-409
143. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32 (2004) 2014-2020
144. Suhocki P.V., Conlon Jr. P.J., Knelson M.H., et al. Silastic cuffed catheters for hemodialysis vascular access. Thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 28 (1996) 379-386
145. Develter W., De Cubber A., Van Biesen W., et al. Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artif Organs 29 (2005) 399-405
146. Mokrzycki M.H., Zhang M., Cohen H., et al. Tunneled haemodialysis catheter bacteraemia. Risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 21 (2006) 1024-1031
147. Capdevila J.A., Segarra A., Planes A.M., et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 8 (1993) 231-234
148. Uldall R., DeBruyne M., Besley M., et al. A new vascular access catheter for hemodialysis. Am J Kidney Dis 21 (1993) 270-277
149. Krishnasami Z., Carlton D., Bimbo L., et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002 61 (2002) 1136-1142
150. Shaffer D. Lessons from vascular access procedures for hemodialysis. Surg Oncol Clin N Am 4 (1995) 537-548